NCT02496923View on ClinicalTrials.gov

High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cardiac Surgery
Interventions
DEVICE

High flow nasal oxygen therapy (Optiflow™)

DEVICE

Standard oxygen therapy (Hudson Type face mask or nasal prongs)

Trial Locations (1)

CB23 3RE

Department of Cardiothoracic Anaesthesia and Critical Care Medicine, Papworth Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors
lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT02496923 - High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients | Biotech Hunter | Biotech Hunter